Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1996-02-23
1997-08-05
Mullis, Jeffrey C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514545, A01N 3702
Patent
active
056543352
ABSTRACT:
A method of reducing intraocular eye pressure by topically applying to an affected eye a small but therapeutically effective intraocular eye pressure reducing amount of the compound ethyl ethacrynate.
REFERENCES:
patent: 3478085 (1969-11-01), Cragoe, Jr.
patent: 4731381 (1988-03-01), Abraham et al.
patent: 4731473 (1988-03-01), Abraham et al.
patent: 4757089 (1988-07-01), Epstein
patent: 4855289 (1989-08-01), Wester et al.
patent: 5244922 (1993-09-01), Burzynski
patent: 5306731 (1994-04-01), Epstein
patent: 5352702 (1994-10-01), Cyrlin
patent: 5395847 (1995-03-01), Weinstock et al.
patent: 5424450 (1995-06-01), Boswell et al.
patent: 5458883 (1995-10-01), Epstein
patent: 5472706 (1995-12-01), Friedman et al.
patent: 5506226 (1996-04-01), May
patent: 5565434 (1996-10-01), Barfknecht et al.
patent: 5585401 (1996-12-01), Brandt et al.
Wang et al., Arch Ophthalmol/vol. 112, Mar. 1994, pp. 390-394.
Tingey et al., Arch Ophthalmol/vol. 110, May 1992, pp. 699-702.
Johnson et al., Current Eye Research/vol. 12 No. 5 1993, 385-396.
Cynkowska et al., Abstract PDD 7145, American Association of Pharmaceutical Scientists, Nov. 1995, p. S-229.
Melamed et al., Abstract of Association Meeting, Association for Research in Vision Ophthalmology (ARVO), (1992).
Barfknecht Charles F.
Schoenwald Ronald D.
Mullis Jeffrey C.
University of Iowa Research Foundation
LandOfFree
Topical use of ethyl ethacrynate for glaucoma treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Topical use of ethyl ethacrynate for glaucoma treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical use of ethyl ethacrynate for glaucoma treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1075209